Effects of Flavor Ban on E-Cigarette Users

Dec.02.2022
Effects of Flavor Ban on E-Cigarette Users
Less than 5% of surveyed adult e-cigarette users quit smoking due to bans, with most switching to alternative tobacco products.

A study published in Tobacco Control revealed that out of 3,500 adult e-cigarette users surveyed, less than 5% quit smoking due to bans. Instead, the majority of respondents turned to other tobacco products not covered by the ban or different flavors of e-cigarettes.


An increasing body of literature suggests that the flavorings in e-cigarettes can cause harm when inhaled, making the ban on flavors reasonable," says Deborah J. Ossip, an expert in tobacco research and professor in the Department of Public Health Sciences and Community Center. The University of Rochester Medical Center's Department of Health and Prevention was a co-author of the study. "However, the ban appears to be ineffective. People, including young people, can still obtain flavored products and are still using them.


Dr. Dongmei Li, Associate Professor of Clinical and Translational Research in Obstetrics and Gynecology and Public Health Sciences at URMC, stated that a major concern is that the ban does not cover disposable e-cigarettes and cartridge-based e-cigarettes that use tanks instead of pods.


Other types of flavored e-cigarettes, especially disposable e-cigarettes, have become very popular after the FDA policy," says Li. "The FDA policy also did not ban mint or tobacco-flavored products - our research shows that many people turned to mint-flavored e-cigarettes after the ban. It seems that many people think that menthol is a good taste.


In the survey of respondents, nearly 30% have switched to canned or disposable flavored e-cigarettes, while another 30% have switched to mint or tobacco flavored pods. 14% have switched to combustible products like cigarettes, 5% have switched to smokeless tobacco, and less than 5% have quit using electronic cigarettes since the ban was enacted.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS submitted a comment letter to USTR in a proceeding examining unfair trade practices worldwide. The letter focuses on illicit nicotine products made in China and shipped to the United States in violation of U.S. law. NACS said the U.S. electronic nicotine delivery systems market has become dominated by illicit products, mainly disposable e-cigarettes manufactured in China and sold without the marketing authorization required by the U.S. Food and Drug Administration.
Apr.16 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
Serbian Parliament Passes Trade Laws Banning Sales of E-Cigarettes and Nicotine Products to Minors
Serbian Parliament Passes Trade Laws Banning Sales of E-Cigarettes and Nicotine Products to Minors
Serbia’s parliament has adopted a package of trade laws aimed at increasing consumer protection while introducing a range of changes for merchants and online platforms. One of the most important new measures is a ban on the sale of e-cigarettes and other nicotine products to minors, tightening youth protection rules.
Apr.24 by 2FIRSTS.ai
Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework
Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework
A new Alberta bill aimed at reducing vaping rates, especially among young people, is moving into the legislative process. Bill 208, the Vaping Reduction Act, was introduced by United Conservative Party MLA Chelsae Petrovic and appears to build on the province’s existing Tobacco, Smoking and Vaping Reduction Act. Early reporting suggests the bill could focus on disposable vapes and impose further limits on youth access to vaping products.
Apr.15 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai